威高血净 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	3.6B	3.5B	3.4B	2.9B	2.6B
Revenue Growth %	2.0%	3.1%	17.7%	10.2%	--
Total Revenue	3.6B	3.5B	3.4B	2.9B	2.6B
Cost Of Revenue	2.1B	2.0B	2.0B	1.6B	1.4B
+Gross Profit	1.5B	1.5B	1.5B	1.4B	1.3B
Gross Margin %	42.3%	43.7%	42.9%	46.5%	48.9%
Total Operating Cost	3.1B	3.1B	3.1B	2.6B	2.3B
Selling Expenses	630.0M	688.0M	687.0M	679.0M	608.0M
Admin Expenses	171.0M	169.0M	198.0M	163.0M	118.0M
Rd Expenses	165.0M	155.0M	183.0M	153.0M	99.2M
Finance Expenses	-5.9M	-4.2M	8.6M	42.0M	59.1M
+Operating Income	552.0M	527.0M	377.0M	327.0M	379.0M
Operating Margin %	15.3%	14.9%	11.0%	11.2%	14.3%
Non Operating Income	1.3M	1.4M	442,100	527,800	1.8M
Non Operating Expenses	8.0M	4.4M	11.6M	8.7M	15.2M
Investment Income	36.2M	25.8M	26.3M	15.9M	7.7M
Fair Value Change Income	223,400	108,200	--	2.2M	-645,300
Asset Disposal Income	202,800	94,000	-14,000	8,300	-710,100
Asset Impairment Loss	8.3M	2.6M	2.6M	-738,200	396,700
Other Income	48.7M	29.0M	27.3M	27.0M	26.7M
Income Before Tax	546.0M	524.0M	366.0M	319.0M	365.0M
Income Tax	96.3M	81.7M	50.9M	59.5M	68.8M
+Net Income	449.0M	442.0M	315.0M	260.0M	297.0M
Net Margin %	12.5%	12.5%	9.2%	8.9%	11.2%
Net Income Attributable	449.0M	442.0M	315.0M	260.0M	297.0M
Eps Basic	1.21	1.19	0.87	0.74	0.89
Eps Diluted	1.21	1.19	0.87	0.74	0.89

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	818.0M	646.0M	589.0M	330.0M	485.0M
Trading Financial Assets	330.0M	70.1M	--	2.3M	--
Accounts Receivable	900.0M	858.0M	1.0B	897.0M	718.0M
Notes Receivable	7.7M	15.4M	44.1M	23.0M	16.5M
Notes And Accounts Receivable	907.0M	873.0M	1.0B	920.0M	735.0M
Prepayments	29.4M	18.3M	30.5M	29.9M	20.6M
Inventory	757.0M	900.0M	661.0M	561.0M	468.0M
Total Current Assets	3.0B	2.7B	2.4B	2.0B	1.8B
Long Term Equity Investment	143.0M	171.0M	127.0M	105.0M	83.2M
Fixed Assets	--	2.7B	2.8B	2.4B	1.9B
Fixed Assets Total	2.6B	2.7B	2.8B	2.4B	1.9B
Construction In Progress	--	668.0M	549.0M	824.0M	1.2B
Construction In Progress Total	768.0M	668.0M	549.0M	824.0M	1.2B
Intangible Assets	296.0M	303.0M	298.0M	306.0M	300.0M
Long Term Deferred Expenses	7.8M	11.5M	16.0M	21.4M	26.5M
Total Non Current Assets	4.0B	4.0B	4.0B	4.0B	3.8B
Total Assets	7.0B	6.7B	6.4B	5.9B	5.5B
Short Term Borrowings	3.2M	6.6M	41.8M	679.0M	673.0M
Accounts Payable	363.0M	625.0M	622.0M	466.0M	394.0M
Contract Liabilities	295.0M	250.0M	293.0M	187.0M	173.0M
Total Current Liabilities	1.3B	1.5B	1.6B	2.2B	1.8B
Long Term Borrowings	--	--	--	--	206.0M
Total Non Current Liabilities	81.6M	91.0M	100.0M	110.0M	379.0M
Total Liabilities	1.4B	1.5B	1.7B	2.3B	2.2B
Paid In Capital	370.0M	370.0M	370.0M	350.0M	350.0M
Capital Reserve	3.7B	3.7B	3.7B	3.0B	2.9B
Surplus Reserve	200.0M	160.0M	113.0M	64.7M	34.5M
Retained Earnings	1.3B	917.0M	522.0M	255.0M	24.6M
Equity Attributable	5.6B	5.1B	4.7B	3.7B	3.3B
Total Equity	5.6B	5.1B	4.7B	3.7B	3.3B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	4.1B	4.4B	3.9B	3.2B	2.8B
Tax Refunds Received	30.7M	12.8M	78.9M	6.1M	4.1M
Total Operating Cash Inflow	4.1B	4.4B	4.0B	3.2B	2.9B
Cash Paid For Goods	2.1B	2.6B	1.9B	1.5B	1.2B
Cash Paid To Employees	570.0M	597.0M	493.0M	478.0M	429.0M
Taxes Paid	374.0M	315.0M	282.0M	272.0M	235.0M
Total Operating Cash Outflow	3.6B	4.1B	3.2B	2.7B	2.3B
Operating Cash Flow	572.0M	288.0M	727.0M	505.0M	611.0M
Total Investing Cash Inflow	2.5B	575.0M	99.8M	183.0M	854.0M
Total Investing Cash Outflow	2.9B	763.0M	342.0M	561.0M	1.4B
Investing Cash Flow	-379.0M	-188.0M	-242.0M	-379.0M	-575.0M
Cash From Borrowings	3.2M	6.6M	480.0M	678.0M	818.0M
Dividends And Interest Paid	--	488,500	18.8M	42.7M	45.8M
Debt Repayments	--	41.8M	1.2B	765.0M	2.1B
Total Financing Cash Inflow	3.2M	6.7M	1.1B	678.0M	2.1B
Total Financing Cash Outflow	18.6M	54.1M	1.3B	924.0M	2.3B
Financing Cash Flow	-15.4M	-47.3M	-222.0M	-246.0M	-177.0M
Net Change In Cash	177.0M	54.1M	266.0M	-121.0M	-142.0M
Ending Cash Balance	796.0M	619.0M	565.0M	298.0M	419.0M
Capex	179.0M	233.0M	280.0M	401.0M	566.0M